OrnipressinCardiovascularSafety Rating 7/10
Primary research areaEsophageal varices
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range0.1 units/min IV infusion
AdministrationIntravenous
Safety7/10 · Approved in some countries
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Ornipressin
Mechanism of action
Ornithine vasopressin analog; potent vasoconstrictor reducing portal and splanchnic pressure
Safety profile
Cardiac ischemia, hypertension, peripheral vasoconstriction · Used clinically for bleeding; ischemic complications at high doses; manageable with monitoring
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Ornipressin below your target.
Related pages